Covid-19 manufacturing roundup: Production ramp-ups approved by EU; mRNA boom spurs Lonza's Chinese expansion
The European Union’s human medicines committee approved a ramp-up in manufacturing capacity for Moderna and Pfizer/BioNTech’s mRNA vaccines Tuesday.
A site …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.